logo

For the Inventor, By the Inventor

Saint Maurice de Gourdans, France

Valérie Guyard-Dangremont

This inventor holds 9 USPTO granted patents and 4 EPO patents. Top assignees: Merck Patent Gmbh, Merck Patent Gesellschaft MIT Beschrankter Haftung. Active years: 2008-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Valérie Guyard-Dangremont. Retrieved from https://idiyas.com/inventor/valérie-guyard-dangremont

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9


Average Co-Inventor Count = 7.2

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:

goldMedal8 out of 3,025 
 
Merck Patent Gmbh
 patents
silverMedal1 out of 1,248 
 
Merck Patent Gesellschaft MIT Beschrankter Haftung
 patents

Years Active: 2008-2012

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents
1. 8247448 - Butenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and use for the treatment of dyslipidaemia, atherosclerosis and diabetes (2012-08-21),
2. 8063067 - Hexenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof (2011-11-22),
3. 7863328 - Phenylbenzoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof (2011-01-04),
4. 7820847 - Butenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them and use for the treatment of dyslipidaemia, atherosclerosis and diabetes (2010-10-26),
5. 7678831 - Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof (2010-03-16),
6. 7632846 - Hexenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof (2009-12-15),
7. 7491747 - Butyric acid derivatives (2009-02-17),
8. 7482484 - Carboxylic acids and derivatives for the treatment of and preventing diabetes and dyslipidaemia (2009-01-27),
9. 7465752 - Pentenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof (2008-12-16),

Title: Valérie Guyard-Dangremont: Innovator in Pharmaceutical Chemistry

Introduction

Valérie Guyard-Dangremont is a notable inventor based in Saint Maurice de Gourdans, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for treating various health conditions. With a total of nine patents to his name, his work has had a considerable impact on medical science.

Latest Patents

Guyard-Dangremont's latest patents include innovative formulations and processes related to butenoic acid derivatives. These compounds are designed for the treatment of dyslipidaemia, atherosclerosis, and diabetes. His work on hexenoic acid derivatives also focuses on similar therapeutic applications, showcasing his commitment to advancing healthcare solutions.

Career Highlights

Throughout his career, Valérie has worked with prominent companies in the pharmaceutical industry, including Merck Patent GmbH and Merck Patent Gesellschaft mit beschränkter Haftung. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research.

Collaborations

He has collaborated with esteemed colleagues such as Francis Contard and Daniel Guerrier, further enhancing the quality and reach of his inventions. These partnerships have played a crucial role in the development of his patented technologies.

Conclusion

Valérie Guyard-Dangremont stands out as a significant figure in pharmaceutical innovation. His contributions through patents and collaborations continue to influence the treatment of critical health issues.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…